140 related articles for article (PubMed ID: 15534342)
1. An exploration of relative health stock in advanced cancer patients.
Gaskin DJ; Weinfurt KP; Castel LD; DePuy V; Li Y; Balshem A; Benson A; Burnett CB; Corbett S; Marshall J; Slater E; Sulmasy DP; Van Echo D; Meropol NJ; Schulman KA
Med Decis Making; 2004; 24(6):614-24. PubMed ID: 15534342
[TBL] [Abstract][Full Text] [Related]
2. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt KP; Castel LD; Li Y; Sulmasy DP; Balshem AM; Benson AB; Burnett CB; Gaskin DJ; Marshall JL; Slater EF; Schulman KA; Meropol NJ
Cancer; 2003 Jul; 98(1):166-75. PubMed ID: 12833469
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
4. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
Schutta KM; Burnett CB
Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ; Weinfurt KP; Burnett CB; Balshem A; Benson AB; Castel L; Corbett S; Diefenbach M; Gaskin D; Li Y; Manne S; Marshall J; Rowland JH; Slater E; Sulmasy DP; Van Echo D; Washington S; Schulman KA
J Clin Oncol; 2003 Jul; 21(13):2589-96. PubMed ID: 12829680
[TBL] [Abstract][Full Text] [Related]
6. Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.
Daugherty CK; Fitchett G; Murphy PE; Peterman AH; Banik DM; Hlubocky F; Tartaro J
Psychooncology; 2005 Feb; 14(2):135-46. PubMed ID: 15386780
[TBL] [Abstract][Full Text] [Related]
7. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
[TBL] [Abstract][Full Text] [Related]
8. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
Markman M; Petersen J; Montgomery R
Cancer; 2006 Aug; 107(4):849-53. PubMed ID: 16832813
[TBL] [Abstract][Full Text] [Related]
9. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
10. An approach to measuring the quality of breast cancer decisions.
Sepucha K; Ozanne E; Silvia K; Partridge A; Mulley AG
Patient Educ Couns; 2007 Feb; 65(2):261-9. PubMed ID: 17023138
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for decision aids in advanced breast cancer?
Sepucha KR; Ozanne EM; Partridge AH; Moy B
Med Decis Making; 2009; 29(4):475-82. PubMed ID: 19329775
[TBL] [Abstract][Full Text] [Related]
12. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
13. Decision-making and breast cancer clinical trials: how experience challenges attitudes.
Mancini J; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; ; Julian Reynier C
Contemp Clin Trials; 2007 Nov; 28(6):684-94. PubMed ID: 17434812
[TBL] [Abstract][Full Text] [Related]
14. Identifying motivations and barriers to patient participation in clinical trials.
Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
[TBL] [Abstract][Full Text] [Related]
15. To be involved or not: factors that influence nurses' involvement in providing treatment decisional support in advanced cancer.
Barthow C; Moss C; McKinlay E; McCullough L; Wise D
Eur J Oncol Nurs; 2009 Feb; 13(1):22-8. PubMed ID: 19010732
[TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
17. Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials.
Weinfurt KP; Depuy V; Castel LD; Sulmasy DP; Schulman KA; Meropol NJ
Cancer; 2005 Jan; 103(1):140-7. PubMed ID: 15534885
[TBL] [Abstract][Full Text] [Related]
18. The experience of older patients with cancer in phase 1 clinical trials: a qualitative case series.
Kvale EA; Woodby L; Williams BR
Am J Hosp Palliat Care; 2010 Nov; 27(7):474-81. PubMed ID: 20388935
[TBL] [Abstract][Full Text] [Related]
19. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
20. Altruism among participants in cancer clinical trials.
Truong TH; Weeks JC; Cook EF; Joffe S
Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
